Advantages of next-generation sequencing for IVF clinics with Dagan Wells | Illumina Video

November 5, 2014

High-throughput, next-generation sequencing for Preimplantation Genetic Screening (PGS) to detect aneuploid embryos is a game changer for IVF clinics and labs. Clinics are increasingly turning to PGS from Illumina for embryo screening. [link to RGH page http://www.illumina.com/clinical/reproductive-genetic-health.ilmn.] Learn about the latest advances in reproductive and genetic health from

Share this article on    
    
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.